Rotavirus immunization: Global coverage and local barriers for implementation
<h4>Background</h4> <p>Rotavirus (RV) is a major agent of gastroenteritis and an important cause of child death worldwide. Immunization (RVI) has been available since 2006. the Federation of International Societies of Gastroenterology Hepatology and Nutrition (FISPGHAN) identified...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2017
|
| _version_ | 1797104395926634496 |
|---|---|
| author | Vecchio, A Liguoro, I Dias, J Berkley, J Boey, C Cohen, M Cruchet, S Salazar-Lindo, E Podder, S Sandhu, B Sherman, P Shimizu, T Guarino, A |
| author_facet | Vecchio, A Liguoro, I Dias, J Berkley, J Boey, C Cohen, M Cruchet, S Salazar-Lindo, E Podder, S Sandhu, B Sherman, P Shimizu, T Guarino, A |
| author_sort | Vecchio, A |
| collection | OXFORD |
| description | <h4>Background</h4> <p>Rotavirus (RV) is a major agent of gastroenteritis and an important cause of child death worldwide. Immunization (RVI) has been available since 2006. the Federation of International Societies of Gastroenterology Hepatology and Nutrition (FISPGHAN) identified RVI as a top priority for the control of diarrheal illness. A FISPGHAN working group on acute diarrhea aimed at estimating the current RVI coverage and identifying barriers to implementation worldwide.</p> <h4>Methods</h4> <p>A survey was distributed to national experts in infectious diseases and vaccinations, and health-care authorities (March 2015 -April 2016), collecting information on local recommendations, costs and perception of barriers to implementation.</p> <h4>Findings</h4> <p>RVI is recommended in 27/49 countries (55%) participating in the survey. Although five countries have recommended RVI since 2006, a large number (16, 33%) included RVI in a National Immunization Schedule between 2012 and 2014. The costs of vaccination are covered by the government (39%), by the GAVI Alliance (10%) or public and private insurance (8%) in some countries. However, in most cases, immunization is paid by families (43%). Elevated costs (49%) and the limited perception of RV illness severity by the families (47%) and public-health authorities (37%) are the major barriers to large-scale RVI programs.</p> <h4>Interpretation</h4> <p>After 10 years since its introduction, the implementation of RVI is still unacceptably low and should remain a major target for global public health. Barriers to implementation vary according to setting. Nevertheless, public health authorities should promote education for caregivers and health-care providers and interact with local health authorities in order to implement RVI</p> |
| first_indexed | 2024-03-07T06:33:15Z |
| format | Journal article |
| id | oxford-uuid:f6c12fbc-0b8a-4931-9e87-8e9202519d61 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T06:33:15Z |
| publishDate | 2017 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:f6c12fbc-0b8a-4931-9e87-8e9202519d612022-03-27T12:37:20ZRotavirus immunization: Global coverage and local barriers for implementationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f6c12fbc-0b8a-4931-9e87-8e9202519d61Symplectic Elements at OxfordElsevier2017Vecchio, ALiguoro, IDias, JBerkley, JBoey, CCohen, MCruchet, SSalazar-Lindo, EPodder, SSandhu, BSherman, PShimizu, TGuarino, A <h4>Background</h4> <p>Rotavirus (RV) is a major agent of gastroenteritis and an important cause of child death worldwide. Immunization (RVI) has been available since 2006. the Federation of International Societies of Gastroenterology Hepatology and Nutrition (FISPGHAN) identified RVI as a top priority for the control of diarrheal illness. A FISPGHAN working group on acute diarrhea aimed at estimating the current RVI coverage and identifying barriers to implementation worldwide.</p> <h4>Methods</h4> <p>A survey was distributed to national experts in infectious diseases and vaccinations, and health-care authorities (March 2015 -April 2016), collecting information on local recommendations, costs and perception of barriers to implementation.</p> <h4>Findings</h4> <p>RVI is recommended in 27/49 countries (55%) participating in the survey. Although five countries have recommended RVI since 2006, a large number (16, 33%) included RVI in a National Immunization Schedule between 2012 and 2014. The costs of vaccination are covered by the government (39%), by the GAVI Alliance (10%) or public and private insurance (8%) in some countries. However, in most cases, immunization is paid by families (43%). Elevated costs (49%) and the limited perception of RV illness severity by the families (47%) and public-health authorities (37%) are the major barriers to large-scale RVI programs.</p> <h4>Interpretation</h4> <p>After 10 years since its introduction, the implementation of RVI is still unacceptably low and should remain a major target for global public health. Barriers to implementation vary according to setting. Nevertheless, public health authorities should promote education for caregivers and health-care providers and interact with local health authorities in order to implement RVI</p> |
| spellingShingle | Vecchio, A Liguoro, I Dias, J Berkley, J Boey, C Cohen, M Cruchet, S Salazar-Lindo, E Podder, S Sandhu, B Sherman, P Shimizu, T Guarino, A Rotavirus immunization: Global coverage and local barriers for implementation |
| title | Rotavirus immunization: Global coverage and local barriers for implementation |
| title_full | Rotavirus immunization: Global coverage and local barriers for implementation |
| title_fullStr | Rotavirus immunization: Global coverage and local barriers for implementation |
| title_full_unstemmed | Rotavirus immunization: Global coverage and local barriers for implementation |
| title_short | Rotavirus immunization: Global coverage and local barriers for implementation |
| title_sort | rotavirus immunization global coverage and local barriers for implementation |
| work_keys_str_mv | AT vecchioa rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT liguoroi rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT diasj rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT berkleyj rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT boeyc rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT cohenm rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT cruchets rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT salazarlindoe rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT podders rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT sandhub rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT shermanp rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT shimizut rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation AT guarinoa rotavirusimmunizationglobalcoverageandlocalbarriersforimplementation |